Cannabinoids in Glaucoma: A Primary Screening Procedure
- 9 August 1981
- journal article
- research article
- Published by Wiley in The Journal of Clinical Pharmacology
- Vol. 21 (S1) , 472S-478S
- https://doi.org/10.1002/j.1552-4604.1981.tb02627.x
Abstract
A procedure was developed for screening of cannabinoids for their ability to reduce intraocular pressure (IOP) using normal rabbits. Eight animals per group were used for statistical significance of data. A negative control group was used for every screen as well as a positive control with 1.5 mg/kg Δ9‐THC given intravenously (I.V.). All compounds were tested by I.V. injection and IOP measurements were taken periodically for 5 hours. Data were analyzed by a computer program which takes into account the change in IOP of the control group. Following this procedure we found that Δ8‐THC, Δ9‐THC, cannabinol, and nabilone were active while cannabidiol was inactive.Keywords
This publication has 10 references indexed in Scilit:
- Effect of Marihuana on Intraocular and Blood Pressure in GlaucomaOphthalmology, 1980
- A comparison of topical cannabinoids on intraocular pressureExperimental Eye Research, 1978
- Effect of Delta-9-Tetrahydrocannabinol on Intraocular Pressure in HumansSouthern Medical Journal, 1977
- Mediation of ocular tetrahydrocannabinol effects by adrenergic nervous systemExperimental Eye Research, 1976
- Method for Antiglaucoma Drug Screening on RabbitsOphthalmic Research, 1976
- The Therapeutic Potential Of MarihuanaPublished by Springer Nature ,1976
- The Ocular Manifestations of the CannabinolsOphthalmologica, 1974
- Pupillary Constriction after Marijuana SmokingAmerican Journal of Ophthalmology, 1972
- Marihuana Smoking and Intraocular PressureJAMA, 1971